Market cap
$263 Mln
Revenue (TTM)
$85 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -4.93 | -7.62 | -36.71 | -7.08 | -10.62 |
| EBIT | -100.76 | -60.57 | -2.96 | -9.02 | -21.84 |
| Net Profit | 40.83 | 20.03 | 27.48 | -0.36 | -11.49 |
| EPS | 41.23 | 22.15 | 29.58 | 21.38 | 11.45 |
| Book Value | -- | -- | -12.51 | -- | -10.06 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -85.39 | -100.08 | -116.87 | -113.30 | -77.39 |
| Net Margin
| -- | -191.63 | -103.29 | -- | -- |
| Return on equity
| -12.49 | -596.81 | -18.12 | -16.72 | -85.82 |
| Return on Capital
| 148.14 | 50.08 | -- | -15.61 | -61.06 |
| Return on Assets
| -21.11 | -28.04 | -13.05 | -12.69 | -29.69 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.07 | 0.07 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
-15.61
|
-61.06
|
521.10
|
-167.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-18.12
Lower than Peers by 23.07
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-18.12
|
-16.72
|
-85.82
|
65.05
|
-2,895.85
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-13.05
Lower than Peers by 15.51
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-13.05
|
-12.69
|
-29.69
|
-20.93
|
-57.13
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-116.87
Lower than Peers by 125.35
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-116.87
|
-113.30
|
-77.39
|
-65.49
|
-192.55
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-103.29
Lower than Peers by 107.97
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-103.29
|
-87.77
|
-79.62
|
-70.21
|
-191.63
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-36.71
Lower than Peers by 45.20
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-36.71
|
-0.51
|
0.64
|
0.09
|
-0.25
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-2.96
Lower than Peers by 13.61
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-2.96
|
28.39
|
-93.86
|
63.08
|
-179.57
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
27.48
Higher than Peers by 13.93
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
27.48
|
46.07
|
-86.03
|
60.73
|
-220.91
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
29.58
Higher than Peers by 9.07
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
29.58
|
0.48
|
0.60
|
0.61
|
-2.10
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
23.81
Higher than Peers by 16.81
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
23.81
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
Lower than Peers by 0.40
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
0.00
|
0.07
|
0.07
|
-0.66
|
-1.26
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
0.01
|
0.01
|
0.01
|
-0.43
|
-0.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
9.10
Higher than Peers by 6.27
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
9.10
|
4.19
|
5.70
|
1.45
|
4.81
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
8.80
Higher than Peers by 6.75
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
8.80
|
4.01
|
5.09
|
1.26
|
4.31
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-6,064.40
Lower than Peers by 6,069.36
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-6,064.40
|
-3,718.31
|
-40.71
|
-15.25
|
-43.55
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.61
Higher than Peers by 2.16
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
18.61
|
15.74
|
19.27
|
18.49
|
17.64
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.13
Lower than Peers by 0.38
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
0.13
|
0.14
|
0.37
|
0.30
|
0.29
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
100.67
|
55.77
|
63.44
|
66.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
259.15
|
124.09
|
137.26
|
126.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
75.50
|
43.58
|
56.04
|
55.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
284.33
|
136.28
|
144.66
|
137.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
-6.58
|
-4.72
|
-2.36
|
-0.49
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
0.46
Lower than Peers by 3.37
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
0.46
|
1.16
|
1.39
|
-1.19
|
-1.14
|
|
Peer Median
|
3.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-19.22
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
-19.22
|
-3.75
|
-3.35
|
-2.93
|
-0.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
263
Lower than Peers by 279
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Standard Biotools Inc (LAB)
|
263
|
--
|
--
|
--
|
--
|
|
Peer Median
|
542
|
--
|
--
|
--
|
--
|